SAM68: A downstream target of angiotensin II signaling in vascular smooth muscle cells in genetic hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 5 55-5, 2004, Pages

  El Mabrouk, Mohammed ^a   Diep, Quy N ^a   Benkirane, Karim ^a   Touyz, Rhian M ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Growth; Renin angiotensin system; Signal transduction; Spontaneously hypertensive rat

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANGIOTENSIN; ANTISENSE OLIGONUCLEOTIDE; DNA; LEUCINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; POLYURIDYLIC ACID; PROTEIN P85; PROTEIN P85 ALPHA; PROTEIN SAM68; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CATALYSIS; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME SUBUNIT; ESSENTIAL HYPERTENSION; GENETIC TRANSFECTION; HEREDITARY HYPERTENSION; IMMUNOPRECIPITATION; INHIBITION KINETICS; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STIMULATION; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOTENSIN II; ANIMALS; CELL DIVISION; CELLS, CULTURED; ENZYME INHIBITORS; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; POLY U; PROTEIN ISOFORMS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 1942469333     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00134.2003     Document Type: Article

References (42)

1. Bai H, Pollman MJ, Inishi Y, and Gibbons GH. Regulation of vascular smooth muscle cell apoptosis. Modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway. Circ Res 85: 229-237, 1999.
2. Barlat I, Maurier F, Duchesne M, Guitard E, Tocque B, and Schweighoffer F. A role for Sam68 in cell cycle progression antagonized by a spliced variant within the KH domain. J Biol Chem 272: 3129-3132, 1997.
3. Benzeroual K, Pandey SK, Srivastava AK, van de Werve G, and Haddad PS. Insulin-induced Ca2+ entry in hepatocytes is important for PI 3-kinase activation, but not for insulin receptor and IRS-1 tyrosine phosphorylation. Biochim Biophys Acta 1495: 14-23, 2000.
4. Bhanot S, Salh BS, Verma S, McNeill JH, and Pelech SL. In vivo regulation of protein-serine kinases by insulin in skeletal muscle of fructose-hypertensive rats. Am J Physiol Endocrinol Metab 277: E299-E307, 1999.
5. Brasier AR, Jamaluddin M, Han Y, Patterson C, and Runge MS. Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor. Mol Cell Biochem 212: 155-169, 2000.
6. Bunnell SC, Henry PA, Kolluri R, Kirchhausen T, Rickles RJ, and Berg LJ. Identification of Itk/Tsk Src homology 3 domain ligands. J Biol Chem 271: 25646-25656, 1996.
7. Cao Z, Dean R, Wu L, Casley D, and Cooper ME. Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy. Hypertension 34: 408-414, 1999.
8. Derry JJ, Richard S, Valderrama CH, Ye X, Vasioukhin V, Cochrane AW, Chen T, and Tyner AL. Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability. Mol Cell Biol 20: 6114-6126, 2000.
9. Duan C, Bauchat JR, and Hsieh T. Phosphatidylinositol 3-kinase is required for insulin-like growth factor-I-induced vascular smooth muscle cell proliferation and migration. Circ Res 86: 15-23, 2000.
10. El Mabrouk M, Touyz RM, and Schiffrin EL. Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR. Am J Physiol Heart Circ Physiol 281: H30-H39, 2001.
11. Fusaki N, Iwamatsu A, Iwashima M, and Fujisawa J. Interaction between Sam68 and Src family tyrosine kinases, Fyn and Lck, in T cell receptor signaling. J Biol Chem 272: 6214-6219, 1997.
12. Gilbert C, Barabe F, Rollet-Labelle E, Bourgoin SG, McColl SR, Damaj BB, and Naccache PH. Evidence for a role for SAM68 in the responses of human neutrophils to ligation of CD32 and to monosodium urate crystals. J Immunol 166: 4664-4671, 2001.
13. Gout I, Middleton G, Adu J, Ninkina NN, Drobot LB, Filonenko V, Matsuka G, Davies AM, Waterfield M, and Buchman VL. Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein. EMBO J 19: 4015-4025, 2000.
14. Guinamard R, Fougereau M, and Seckinger P. The SH3 domain of Bruton's tyrosine kinase interacts with Vav, Sam68 and EWS. Scand J Immunol 45: 587-595, 1997.
15. Higaki M and Shimokado K. Phosphatidylinositol 3-kinase is required for growth factor-induced amino acid uptake by vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 2127-2132, 1999.
16. Intengan HD, Thibault G, Li JS, and Schiffrin EL. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 100: 2267-2275, 1999.
17. Jabado N, Jauliac S, Pallier A, Bernard F, Fischer A, and Hivroz C. Sam68 association with p120GAP in CD4+ T cells is dependent on CD4 molecule expression. J Immunol 161: 2798-2803, 1998.
18. Lang V, Mege D, Semichon M, Gary-Gouy H, and Bismuth G. A dual participation of ZAP-70 and scr protein tyrosine kinases is required for TCR-induced tyrosine phosphorylation of Sam68 in Jurkat T cells. Eur J Immunol 27: 3360-3367, 1997.
19. Lawe DC, Hahn C, and Wong AJ. The Nck SH2/SH3 adaptor protein is present in the nucleus and associates with the nuclear protein SAM68. Oncogene 14: 223-231, 1997.
20. Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, and Samuel JL. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 98: 418-425, 1996.
21. Li E, Stupack DG, Brown SL, Klemke R, Schlaepfer DD, and Nemerow GR. Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry. J Biol Chem 275: 14729-14735, 2000.
22. Li JS, Touyz RM, and Schiffrin EL. Effects of AT1 and AT2 angiotensin receptor antagonists in angiotensin II-infused rats. Hypertension 31: 487-492, 1998.
23. Lin Q, Taylor SJ, and Shalloway D. Specificity and determinants of Sam68 RNA binding. Implications for the biological function of K homology domains. J Biol Chem 272: 27274-27280, 1997.
24. Liu K, Li L, Nisson PE, Gruber C, Jessee J, and Cohen SN. Neoplastic transformation and tumorigenesis associated with sam68 protein deficiency in cultured murine fibroblasts. J Biol Chem 275: 40195-40201, 2000.
25. Otsuka S, Sugano M, Makino N, Sawada S, Hata T, and Niho Y. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension 32: 467-472, 1998.
26. Page K, Li J, Wang Y, Kartha S, Pestell RG, and Hershenson MB. Regulation of cyclin D1 expression and DNA synthesis by phosphatidyl-inositol 3-kinase in airway smooth muscle cells. Am J Respir Cell Mol Biol 23: 436-443, 2000.
27. Peng H, Moffett J, Myers J, Fang X, Stachowiak EK, Maher P, Kratz E, Hines J, Fluharty SJ, Mizukoshi E, Bloom DC, and Stachowiak MK. Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. Mol Biol Cell 12: 449-462, 2001.
28. Ruiz-Ortega M, Lorenzo O, Ruperez M, Konig S, Wittig B, and Egido J. Angiotensin II activates nuclear transcription factor kappaB through ATI and AT2 in vascular smooth muscle cells: molecular mechanisms. Circ Res 86: 1266-1272, 2000.
29. Sabri A, Levy BI, Poitevin P, Caputo L, Faggin E, Marotte F, Rappaport L, and Samuel JL. Differential roles of AT1 and AT2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscler Thromb Vasc Biol 17: 257-264, 1997.
30. Sanchez-Margalet V and Najib S. p68 Sam is a substrate of the insulin receptor and associates with the SH2 domains of p85 PI3K. FEBS Lett 455: 307-310, 1999.
31. Saward L and Zahradka P. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 81: 249-257, 1997.
32. Schiffrin EL, Park JB, Intengan HD, and Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 101: 1653-1659, 2000.
33. Shepherd PR, Withers DJ, and Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 333: 471-490, 1998.
34. Shigematsu K, Koyama H, Olson NE, Cho A, and Reidy MA. Phosphatidylinositol 3-kinase signaling is important for smooth muscle cell replication after arterial injury. Arterioscler Thromb Vasc Biol 20: 2373-2378, 2000.
35. Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, and Izumo S. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19: 2537-2548, 2000.
36. Taylor SJ and Shalloway D. An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis. Nature 368: 867-871, 1994.
37. Touyz RM and Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52: 639-672, 2000.
38. Vernet C and Artzt K. STAR, a gene family involved in signal transduction and activation of RNA. Trends Genet 13: 479-484, 1997.
39. Wang LL, Richard S, and Shaw AS. P62 association with RNA is regulated by tyrosine phosphorylation. J Biol Chem 270: 2010-2013, 1995.
40. Wilden PA, Agazie YM, Kaufman R, and Halenda SP. ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am J Physiol Heart Circ Physiol 275: H1209-H1215, 1998.
41. Yang H and Raizada MK. Role of phosphatidylinositol 3-kinase in angiotensin II regulation of norepinephrine neuromodulation in brain neurons of the spontaneously hypertensive rat. J Neurosci 19: 2413-2423, 1999.
42. Yin Y, Terauchi Y, Solomon GG, Aizawa S, Rangarajan PN, Yazaki Y, Kadowaki T, and Barrett JC. Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature 391: 707-710, 1998.